Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Biotechnology industry leader Centocor Ortho Biotech is now Janssen Biotech, Inc., part of the Janssen pharmaceutical companies
Regulation of Neuroinflammation through Programed Death-1/Programed Death Ligand Signaling in Neurological Disorders.
Endogenous and recombinant type I interferons and disease activity in multiple sclerosis.
Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis.
Association between pathological and MRI findings in multiple sclerosis.
Consensus statements from a panel of u.s. Managed care pharmacists and physicians for management of multiple sclerosis agents.
Fibrinogen-induced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation.
Impact of intermittent catheterization on the quality of life of multiple sclerosis patients.
The risk of Bipolar Disorders in Multiple Sclerosis.
Early MRI activity predicts treatment nonresponse with intramuscular interferon beta-1a in clinically isolated syndrome.
Extracranial Venous Drainage Patterns in Patients with Multiple Sclerosis and Healthy Controls.
Naltrexone prescribing information
Variables associated with patient activation in persons with multiple sclerosis.
TAPP1 inhibits the differentiation of oligodendrocyte precursor cells via suppressing the Mek/Erk pathway.
Th17 Cells: Biology, Pathogenesis of Autoimmune and Inflammatory Diseases, and Therapeutic Strategies.
Accentia Biopharmaceuticals Announces that Revimmune Autoimmune Disease Therapy is Featured in Peer-review Journal
Can we overcome the 'clinico-radiological paradox' in multiple sclerosis?
The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
Clonally expanded mitochondrial DNA deletions within the choroid plexus in multiple sclerosis.
Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.
Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis.
A cross-sectional study examining multiple mobility device use and fall status among middle-aged and older adults with multiple sclerosis.
DYNACIN (MINOCYCLINE)
Progressive multifocal leukoencephalopathy after natalizumab discontinuation.
Inhibition of Interferon-beta Responses in Multiple Sclerosis Immune Cells Associated With High-Dose Statins.

Pages